Site is Being Upgraded

Life-extension therapy: Panzoprazole, a drug used in the treatment of stomach and duodenal ulcers,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 7/February/2018, 7.19 pm

Molecular therapy for Stroke: β-Hydroxybutyric acid (BHB) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits via up regulation of its target genes BDNF and NAMPT, 7/January/2018, 7.04 pm
February 7, 2018
Molecular therapy for Anti-ageing and Lifespan extension:  Lansoprazole, a drug used in the treatment of stomach and duodenal ulcers,  increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 7/February/2018, 10.17 pm
February 7, 2018
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published, in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ), by Prof Dominic J. Withers, Dr. Selman C and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that:  Life-extension therapy: Panzoprazole, a drug used in the treatment of stomach and duodenal ulcers, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span



Research findings to Therapeutic opportunity: 

Figure 1. Mechanistic insight into how Panzoprazole may extend lifespan. Panzoprazole inhibits p70 S6 kInase expression and promotes longevity

Panzoprazole, by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).   

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “Panzoprazole  or its analogs, either alone or in combination with any of the known longevity-promoting compound(s)” may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How Panzoprazole decreases the expression of p70 S6 Kinase and promote mammalian life span

# Research cooperation

Amount: $100#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L., Life-extension therapy: Panzoprazole, a drug used in the treatment of stomach and duodenal ulcers,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 7/February/2018, 7.20 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.